Navigation Links
U.S. Cancer Patients Face Barriers to Care, Study Finds
Date:6/3/2011

FRIDAY, June 3 (HealthDay News) -- For newly diagnosed cancer patients, appointments with an oncologist are hard to come by -- even among those with private health insurance, according to U.S. researchers.

The study found that in two-thirds of cases, research assistants posing as new cancer patients were unable to obtain an appointment with an oncologist for an initial exam.

The findings, from a team at the Perelman School of Medicine at the University of Pennsylvania, are slated for presentation on Saturday at the annual meeting of the American Society of Clinical Oncology in Chicago.

"Although health care reform is likely to expand health insurance coverage to more Americans, our research shows that even with insurance, patients face barriers when they try to access cancer care," the study's lead author, Dr. Keerthi Gogineni, instructor in the division of Hematology-Oncology at Penn's Abramson Cancer Center, said in a university news release.

"Given the typical pre-appointment expectations for new patients -- which typically involve referral requirements, paperwork and routing of medical records and test results -- both insured and uninsured patients must contend with many challenges that delay care with a specialty cancer provider," Gogineni added.

In conducting the study, the research assistants pretended to be cancer patients either with or without insurance and attempted to call 160 hospitals to schedule initial oncology visits. Although the callers reached someone who schedules appointments 79 percent of the time, only 29 percent of the callers were actually given appointments.

Among the reasons why the callers were denied oncology appointments were demand for medical records (39 percent), inability to reach the appropriate schedulers (24 percent), and referral requirements (18 percent).

The study authors suggested that, as the number of people living with cancer is on the rise, patients would benefit from more guidance during the initial phase of their care.

"Patients who are newly diagnosed with cancer may be confused or frightened," study co-author Dr. Katrina Armstrong, chief of the division of General Internal Medicine and associate director of Outcomes and Delivery in the Abramson Cancer Center, said in the news release.

"Asking them to find their way through the complex process of obtaining imaging studies and other tests or collecting records from another doctor prior to scheduling an appointment may pose an undue burden, and cancer centers should be prepared to provide help with those preliminary steps," Armstrong urged.

Because this study was presented at a medical meeting, the data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

More information

The American Cancer Society provides insight on what cancer patients can expect during their first oncology appointment.

-- Mary Elizabeth Dallas

SOURCE: University of Pennsylvania School of Medicine, news release, June 1, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FSU scientist leads research on AIDS-related cancer
2. In the lab and clinic, VCU Massey develops a new therapy for blood cancers
3. ASCO: Experimental vaccine made from frozen immune cells shows promise for prostate cancer patients
4. ASCO: Emerging trends in radiation therapy for women over 70 with early stage breast cancer
5. U of Alberta researchers hoping to stop heart disease in cancer patients before it starts
6. Antifungal drug delays need for chemo in advanced prostate cancer
7. Combination therapy shows promise for rare, deadly cancer caused by asbestos
8. Cause and potential treatment found for cancer drugs kidney toxicity
9. Higher doses of radiation in fewer treatments proved safe, effective for low-risk prostate cancer
10. Silencing a deadly conversation in breast cancer
11. IMRT cuts GI side effects from prostate cancer in half vs. 3D-CRT
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.S. Cancer Patients Face Barriers to Care, Study Finds
(Date:4/26/2017)... ... April 26, 2017 , ... Bioclinica® ... sponsors and CROs to speed clinical development, has released the industry’s only ... Bioclinica AGILE RTSM provides seamless clinical supply forecasting and management together ...
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
(Date:4/25/2017)... ... 2017 , ... As pharmaceutical companies are held to increasingly ... innovation in drug formulation and manufacturing. CoreRx offers its clients more than ... support of their development and manufacturing goals. , The company was created ...
(Date:4/25/2017)... Scotch Plains, NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD ... with the treatment of acute or chronic problems, I focus on preventative care with all ... patient. If you have any questions, always feel free to contact my office and my ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: